resources

Cipla Ltd.

NSE: CIPLA

BSE: 500087

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

1,314.60-15.0 (-1.13%)

14 Oct, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Cipla Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Jun Sept Dec	Jun
Conference Calls	—	—	—	—	—	—	—	—	2Feb 18May 18May 10Aug 31Oct	29Jan 17May 2Aug 8Nov	30Jan 16May 29Jul 31Oct	29Jan 15May 29Jul 2Nov	31Jan 16May 28Jul 3Nov	9Jan 27Jan 15May 27Jul
Presentations	—	—	—	—	—	—	—	—	29Jan 14May 5Aug 26Oct	25Jan 10May 29Jul 4Nov	25Jan 12May 26Jul 27Oct	22Jan 13Feb 10May 26Jul	28Jan 18Feb 13May 25Jul 30Oct	23Jan 13May 23Jul

Corporate Announcements and Regulatory Filings

Cipla Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Analyst / Investor Meet13 Oct 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find enclosed intimation for Earnings Conference Call.
Board Meeting28 Sept 2026
Board Meeting Intimation for The Quarter And Half Year Ended 30Th September, 2026 Under SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Cipla Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve the unaudited standalone and consolidated ....
Allotment of ESOP / ESPS24 Sept 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
In terms of Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby notify that the Operations and Administrative Committee of the Company on 24th September, 2026 has allotted 12,168 ....
Change in Management22 Sept 2026
Announcement under Regulation 30 (LODR)-Change in Management
Please find enclosed disclosure relating to the Change in SMP.
General18 Sept 2026
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find enclosed disclosure on ESG Rating.
Press Release / Media Release3 Sept 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed press release titled ''Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda (Pembrolizumab) in the US''
General3 Sept 2026
Notice To Shareholders And Creditors In Accordance With NCLT Order Dated 18Th August, 2026 Regarding Merger Of Inzpera Healthsciences Limited With The Company
Please find enclosed disclosure
Newspaper Publication2 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached newspaper publication regarding opening of special window for re-lodgement of transfer and dematerialisation of physical shares
Press Release / Media Release31 Aug 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed press release titled "Cipla and SBP Group sign exclusive licensing agreement for potential best-in-class HER2 bispecific ADC Rolditamig Deuderuxtecan (TQB2102)"
General28 Aug 2026
Update On USFDA Inspection At Invagen Manufacturing Facility In Central Islip, Long Island, NY, USA
Please find enclosed disclosure.
Restructuring27 Aug 2026
Announcement under Regulation 30 (LODR)-Restructuring
Please find enclosed disclosure.
Analyst / Investor Meet27 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / ....
Allotment of ESOP / ESPS26 Aug 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
In terms of regulation 30 of SEBI (LODR) Regulations, 2015, we hereby notify that the Operations and Admisnistrative Committee of the Company on 26th August, 2026 has allotted 5,281 fully ....
General25 Aug 2026
USFDA Inspection At Company'S Manufacturing Facility In Pithampur, India
Please find enclosed disclosure
Scheme of Arrangement19 Aug 2026
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Cipla has informed the exchange about receipt of order from Hon''ble NCLT, Mumbai Bench
General11 Aug 2026
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find attached disclosure on ESG Ratings.
General4 Aug 2026
Update On USFDA Inspection At Invagen Manufacturing Facility In Hauppauge, Long Island, New York, USA
Please find enclosed intimation.
Allotment of ESOP / ESPS31 Jul 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirments) Regulations, 2015, we hereby notify that the Operations and Administrative Committee ....
General27 Jul 2026
Cipla Receives U.S. FDA Approval For Generic Advair Diskus®
Please find enclosed disclosure
Newspaper Publication24 Jul 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached newspaper intimation for unaudited financial results for the quarter ended 30th June, 2026.

Frequently Asked Questions

Where can I download the annual report of Cipla Ltd.?

Annual reports of Cipla Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Cipla Ltd.?

Quarterly earnings results and presentations of Cipla Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Cipla Ltd. publish earnings call transcripts?

Earnings call transcripts of Cipla Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Cipla Ltd.?

Investor presentations and annual day presentations of Cipla Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Cipla Ltd.?

Corporate announcements and regulatory filings of Cipla Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Cipla Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Cipla Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Cipla Ltd.?

The ISIN (International Securities Identification Number) of Cipla Ltd. is INE059A01026. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Cipla Ltd. listed?

Cipla Ltd. is listed on NSE and BSE. The NSE symbol is CIPLA and the BSE code is -.

Where can I find the shareholding pattern of Cipla Ltd.?

The quarterly shareholding pattern of Cipla Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Cipla Ltd. on Sharpely?

Share price data for Cipla Ltd. is updated as of 14 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.